Home index


Welcome to Michel L. Tremblay lab online. My lab has been established at McGill University (Montreal, Quebec, Canada) since March 1992. Over 60 researchers, students, postdoctoral fellows and supporting staffs have been or are currently committed to our research projects.

In order to understand and find cures for human diseases, my lab focuses on protein tyrosine phosphatases (PTPases). PTPases regulate various signaling pathways in cells, playing essential roles in many biological and pathological processes. To date, my lab has successfully shown that PTPases play key roles in diabetes, obesity, spinal cord injury and infectious diseases as well as in diverse cancers. We believe that our studies will lead to the development of new treatments for a broad range of human diseases.

Among the PTPases, our special interests are towards the following enzymes: PTP1B, TC-PTP, PTP-PEST, RPTP-sigma and PRL-2. We are investigating their 1) physiological and pathological functions, 2) molecular mechanisms of action, and we are also 3) developing drugs to modulate the functions of these targeted PTPases.

For more details of our research projects, click here.

Current granting agencies (Sep. 2015 ):

1) Prostate Cancer Canada
2) Canadian Institute of Health Research
3) Ministère de l'Économie, de l'Innovation et des Exportations Québec
4) Aligo Innovation
5) Kanyr Pharma
6) Merck Sharp & Dohme Corp \ McGill University
7) Leukemia & Lymphoma Society of Canada
8) Canadian Cancer Society
9) Richard And Edith Strauss Canada Foundation
10) Foundation J Louis Levesque
11) McGill University
12) Fonds de recherche du Quebec

Former Granting agencies (since 2007):

1) Terry Fox Research Institute
2) Cancer Research Society
3) US ARMY Department of Defense

Lab Members
Members Only
McGill University McGill University The Rosalind and Morris Goodman Cancer Centre The Rosalind and Morris Goodman Cancer Centre